HK Stock MarketDetailed Quotes

00926 BESUNYEN

Watchlist
  • 2.290
  • +0.060+2.69%
Market Closed May 2 16:08 CST
279.99MMarket Cap17.48P/E (TTM)

About BESUNYEN Company

Bishengyuan Holdings Limited (the “Company”) was established in September 2000 and listed on the main board of the Hong Kong Stock Exchange in September 2010 (stock code HK00926). Bishengyuan Holdings Co., Ltd. and its subsidiaries (collectively, the “Group”) are leading suppliers of functional health teas in the People's Republic of China (“China”), mainly engaged in research and development, production of health products, and sales and promotion of pharmaceuticals and foods. The Group uses “one vertical and two horizontal” as its guideline: one vertical means focusing on herbal plants and health and wellness; two horizontal refers to expanding new businesses in the fields of “weight loss and weight management” and “intestinal cleansing and gastrointestinal health.” For more than 20 years, the Group has produced and sold Bishengyuan brand Changrun tea and Bishengyuan brand Changjing tea (formerly “Bishengyuan brand weight loss tea”) (collectively known as “two teas”) based on the concept of “herbal, healthy, and functional tea”. The Group continues to be deeply involved in the two tea business and has successively launched a series of functional tea products such as Bishengyuan brand fiber tea and Bishengyuan brand Qingyuan tea (collectively known as “four teas” with two teas). In recent years, the Group has also launched Bishengyuan brand orlistat diet drugs and a series of products to meet consumer needs, such as nutritional meal replacements, probiotics, and enzymes. All four teas in the Group are developed, prepared, and produced according to scientific standards using natural Chinese herbal medicines and tea leaves to provide safe, effective, easy to use, and affordable health care products for people with needs for bowel relief and weight management, or whose health and quality of life are moderately affected by them. The Group's four tea production base is located in Fangshan District, Beijing. The plant and production process meet national GMP standards. The production workshop is fully managed, and the granulation workshop and inner packaging workshop are all 100,000-grade clean areas. The Group's four tea products have all passed ISO9001, ISO22000, and HACCP system certifications. The main production equipment is the C24 high-speed tea bag model introduced from IMA in Italy. It has a specially designed “cotton crew knot” to connect the tea bag to the tag. The inner and outer bags are formed once, and the entire packaging process is automatically completed.

Company Profile

Symbol00926
Company NameBESUNYEN
ISINKYG107051123
Listing DateSep 29, 2010
Issue Price3.12
Shares Offered420.28M share(s)
FoundedAug 5, 2009
Registered AddressCayman Islands
Chairmanyihong zhao
Secretaryhongjiang yu
Audit InstitutionPricewaterhouseCoopers
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeThe Grand Pavilion Commercial Centre Oleander Way, 802 West Bay Road P.O. Box 32052 Grand Cayman KY1-1208 Cayman Islands
Head Office and Principal Place of Business5th floor, Lilly Commercial Building, 57-59 Hollywood Road, Central, Hong Kong
Fiscal Year Ends12-31
Employees128
MarketHong Kong motherboard
Phone(852) 3970 2110
Fax(852) 2598 1588
Emailir@besunyen.com
Business Bishengyuan Holdings Co., Ltd. is a company mainly engaged in the production and sale of functional health tea products. The company operates its business through two divisions. The Tea Products Division is engaged in the production and sale of other tea products including Changrun tea, Changjing tea, fiber tea, Qingyuan tea, etc. The Weight Loss and Other Drugs Division sells weight loss and other drugs, such as orlistat diet drugs, nutritional meal replacements, probiotics, enzymes, etc. The company sells its products under the “Bishengyuan” brand. The company's product functions include weight loss, bowel relief, physical fatigue relief, sleep improvement, melasma removal, immunity enhancement, and blood sugar reduction. The company mainly operates in the domestic market.

Company Executives

  • Name
  • Position
  • Salary
  • yihong zhao
  • Chairman, CEOs, Executive Director, Nomination Committee Members, Remuneration Committee Members, Strategy Committee Members, Authorized Representative
  • --
  • yan gao
  • Vice Chairman, Executive Director, Group Vice President
  • --
  • yuanping he
  • Independent Non-Executive Director, Chairman of the Audit Committee, Strategy Committee Members, Nomination Committee Members, Remuneration Committee Members
  • --
  • xiangxin shi
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members, Remuneration Committee Members
  • --
  • bing feng
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • --
  • jian liu
  • Group Vice President
  • --
  • hongjiang yu
  • VP, Executive Director, Chief Financial Officer, Chief Operating Officer, Chairman of the Strategic Investment Committee, Nomination Committee Members, Remuneration Committee Members, Authorized Representative, Company Secretary
  • --
  • ming yang
  • VP
  • --
  • ruhai lin
  • Group Vice President
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More